Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8624515 | 8747387 | I | 8624515-5 | 20120820 | 20120827 | EXP | US-JNJFOC-20120810595 | JANSSEN PHARMACEUTICALS, INC. | YR | F | Y | 20120827 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8624515 | 1020674021 | PS | XARELTO | 1 | ORAL | 022406 | |||||
| 8624515 | 1020674020 | SS | XARELTO | 1 | ORAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8624515 | 1020674021 | HIP SURGERY |
| 8624515 | 1020674020 | THROMBOSIS PROPHYLAXIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8624515 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 8624515 | PLATELET COUNT INCREASED |
| 8624515 | INTERNATIONAL NORMALISED RATIO INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |